Test Directory
| Test Code | ||||
| LPLA2 | ||||
| Test Name | ||||
| Lp-PLA2, Lipoprotein-Associated Phospholipase | ||||
| CPT Codes | ||||
| 83698 | ||||
| Expected Turnaround Time | ||||
| 2 - 4 days | ||||
| Clinical Utility | ||||
|
The PLAC® test for Lp-PLA2 Activity is an enzyme assay for the in vitro quantitative determination of Lp-PLA2 (lipoprotein-associated phospholipase A2) activity in EDTA plasma and serum. Lp-PLA2 activity is to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events. |
||||
| Specimen and Container Info | ||||
|
Preferred Specimen Type: Serum Alternate Specimen type: Plasma
Preferred Collection Container: Gold Top, Serum Separator Alternate Collection Container: Red Top, Plain or Lavender Top (EDTA) Desired Specimen Volume: 0.5 mL |
||||
| Collection Instructions | ||||
|
||||
| Processing and Submission Instructions | ||||
|
||||
| Transport Instructions | ||||
|
Transport to the laboratory refrigerated. |
||||
| Stability Requirements | ||||
|
||||
| Causes for Rejection | ||||
|
||||
| Methodology | ||||
| Quantitative Enzymatic/Spectrophotometry | ||||
| Reference Intervals | ||||
|
See patient report. |
||||
| Alternate Names | ||||
|
||||
| Reference Lab | ||||
| Labcorp Of America Holdings | ||||
| Testing Schedule | ||||
| Monday-Friday | ||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.